Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.




There is on-going development of  generic  EU CTD Dossier of Repaglinide, tablets, 0.5/1/2 mg.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs.

Repaglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. This depolarizes the beta cells, opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion.

More details at: http://www.rxlist.com/prandin-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 590

Advertiser details

Contact Advertiser

Add comment


Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

Lokking for EU CTD Dossiers for traditional...
Member of  Farmavita.Net from EU is looking to...
We are looking to acquire Azathioprine tablet...
I am looking for a good quality dossier with...
We offer for outlicensing European e-CTD...
Novel herbal based throat pastilles with...
We are looking for EU-CTD dossier...